Skip to content

Biotronik DFH Unipolar PE-60/4-DFH

by Biotronik Sales, Inc.

510(k) K833106

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK833106 Date20 Oct 1983ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Biotronik DFH Unipolar PE-60/4-DFH is a Permanent Pacemaker Electrode, classified as a Class III device under FDA regulations. This unipolar electrode is designed for implantation in the cardiovascular system to deliver pacing stimuli, supporting cardiac rhythm management in patients requiring chronic pacing therapy.

This device is intended for single-use implantation and is supplied sterile. It is regulated under FDA 510(k) clearance (K833106) and falls under the product code DTB. The electrode is intended for use in a clinical setting by trained healthcare professionals, adhering to standard sterile procedures for pacemaker lead implantation. No MRI safety information or reusable specifications are provided in the data.

Other devices from Biotronik Sales, Inc.

See all devices from Biotronik Sales, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is this pacemaker electrode designed for reuse in multiple patients, or is it intended for single-use only?

    The Biotronik DFH Unipolar PE-60/4-DFH is explicitly intended for single-use implantation only. The device is supplied sterile, which aligns with single-use medical devices meant to be implanted in a single patient to avoid contamination risks. Reuse is not supported or documented in the provided specifications.

  • What types of storage conditions are recommended for this device before implantation?

    Since the device is supplied sterile and intended for single-use, it should be stored in its original packaging under controlled conditions to maintain sterility. While exact storage details (e.g., temperature, humidity) aren’t specified, standard sterile medical device storage practices—such as keeping it in a clean, dry environment away from direct sunlight—are advised. Always follow manufacturer instructions if additional guidance is provided.

  • Can this electrode be used with any pacemaker system, or is it compatible only with specific Biotronik devices?

    The Biotronik DFH Unipolar PE-60/4-DFH is designed as a permanent pacemaker electrode for use in Biotronik’s pacing systems, but compatibility specifics (e.g., pacemaker models) aren’t detailed in the provided data. Clinicians should verify compatibility with their chosen pacemaker system by consulting Biotronik’s technical documentation or support resources, as electrode-pacemaker pairing is critical for safe and effective cardiac rhythm management.

  • How do I know if this device is the correct size for my patient’s anatomy?

    The model name PE-60/4-DFH includes a 60 cm length designation, which is a key sizing parameter for pacemaker leads. The ‘4’ may refer to the electrode’s design (e.g., tines or fixation mechanism), but exact anatomical fit depends on the patient’s venous anatomy and implantation site. Clinicians should measure the patient’s venous pathway pre-procedure and confirm the lead’s length and fixation type align with their needs, as improper sizing can affect pacing performance or lead stability.

  • What should I consider when handling this device to ensure sterility is maintained during implantation?

    The device is supplied sterile, so it must be handled using aseptic techniques throughout the procedure. This includes keeping the packaging intact until immediate use, avoiding contamination (e.g., touching the electrode with gloved hands), and adhering to sterile field protocols during implantation. Since it’s single-use, any breach of sterility—such as improper packaging handling—would invalidate the device for use, requiring replacement with a new sterile unit.